Antibody and use thereof for the treatment of cancer
AssigneeConsejo Superior de Investigaciones Cientificas
InventorsJosé Ignacio CASAL ÁLVAREZ, Rubén Álvaro BARTOLOME CONDE, Marta JAÉN CASTAÑO
Life of this patent
Estimating the term…
Loading patent…
AssigneeConsejo Superior de Investigaciones Cientificas
InventorsJosé Ignacio CASAL ÁLVAREZ, Rubén Álvaro BARTOLOME CONDE, Marta JAÉN CASTAÑO
Estimating the term…
The present invention relates to a monoclonal antibody that specifically binds to an epitope comprising the amino acid sequence SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or SEQ ID NO: 5 and capable of blocking the binding of IL-13 to IL13Rα2 or inhibiting the IL13/IL13Rα2 signaling, as well as the antiserum, the kit and the pharmaceutical composition comprising said monoclonal antibody. The invention also relates to the use of the antibody, the antiserum and the pharmaceutical composition in the treatment of cancer, specifically, cancer metastasis.
1-20. (canceled)
A monoclonal antibody that specifically binds to an epitope comprising the amino acid sequence SEQ ID NO:
Dependencies are inferred from the claim text.